News

CENTOGENE Smartphone App myLSDapp Now Available in Spanish

Mar 24, 2020

Gaucher Disease Monitoring and Treatment Management

Cambridge, MA USA & Rostock, Germany, March 24, 2020 – CENTOGENE...

CENTOGENE Announces Commencement of Testing for COVID-19

Mar 18, 2020

Cambridge, MA, USA & Rostock/Berlin, Germany, March 18, 2020 (Global Newswire) – CENTOGENE (Nasdaq: CNTG), a...

CENTOGENE Announces Changes in Supervisory Board

Mar 17, 2020

Cambridge, MA, USA and Rostock/Berlin, Germany, March 17, 2020 (Global Newswire) – CENTOGENE N.V. (Nasdaq: CNTG), a...

CENTOGENE Announces Departure of Dirk Ehlers From Executive Board

Mar 09, 2020

Cambridge, MA, USA and Rostock/Berlin, Germany, March 9, 2020 – CENTOGENE (Nasdaq: CNTG) ─ The Company today announced...

CENTOGENE, OMER, and ALIBER’s Rare Disease Day Event in Mexico City 2020: Inspiring Insights on Patient Organizations’ Contributions to Solutions for Patients in Latin America

Feb 29, 2020

Mexico City, February 29, 2020 - More than 300 participants gathered on Saturday at Hotel Marriot Reforma in Mexico City...

CENTOGENE Marks Rare Disease Day 2020 With a Global Line up of Events

Feb 29, 2020

Cambridge, MA, USA & Rostock/Berlin, Germany, February 29, 2020 – CENTOGENE (Nasdaq: CNTG), a commercial-stage company...

Rare Disease Associations Fight for Better Patient Health Care

Feb 28, 2020

On Saturday, February 29th, CENTOGENE, OMER, and ALIBER will celebrate International Rare Disease Day with an event for...

CENTOGENE Expands Senior Leadership Team with Newly Appointed Chief Data Officer

Feb 25, 2020

Cambridge, MA, USA & Rostock, Germany – February 25, 2020 – CENTOGENE (Nasdaq: CNTG), a commercial-stage company...

CENTOGENE Biobank Receives Accreditation from College of American Pathologists

Feb 12, 2020

State-of-the-art Biorepository in Rostock, Germany is the first CAP-accredited repository outside the U.S.

Cambridge,...

CentoMD® Update Reveals Continued Growth of Rare Hereditary Disease Knowledge Base

Dec 13, 2019

Supporting Patients for Accelerated Diagnosis and Treatment Development

Cambridge, MA USA & Rostock, Germany December...

1
2
3
....
13
Next

Press Contact

For further inquiries please contact:

Ben Legg

Corporate Communications

Send Email

Newsletter subscription

First Name

Last Name

Email *

Country

To receive the latest news and developments in clinical diagnostics and scientific breakthroughs in the rare disease field please click subscribe. After that, you will receive an email with a confirmation link. Once you have clicked on that link, we will inform you about our products, services and upcoming events per e-mail. You can unsubscribe from the newsletter with effect for the future at any time using the unsubscribe link contained in every newsletter.

Scientific articles

A Novel Neurodevelopmental Disorder

Brain development is a highly complex process involving numerous proteins. The latest addition to this list is YIF1B: its absence due to bi-allelic inactivating mutations results in a severe neurological disorder.

Article Jan 31, 2020 with topic Mutation Database, Neurology, WES, WGS

Read more
Personalizing Therapeutic Decisions in Fabry Disease

More than a single treatment option is available for some genetic disorders. For Fabry Disease, the optimal choice requires biochemical characterization of the causative mutation. Using a novel assay, researchers from…

Article Jan 31, 2020 with topic Biomarker, Cardiovascular, Mutation Database, Metabolic Disorders, Neurology

Read more
Frequent Genetic Cause of Seizures Identified

The etiology of seizures is highly heterogeneous and involves an unknown number of distinct genetic disorders. An international team of researchers recently defined recessive mutations in the UGDH gene as a novel and…

Article Jan 30, 2020 with topic Neurology, Mutation Database, WES, WGS

Read more